Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Condition:   Mycosis Fungoides Intervention:   Drug: Brentuximab vedotin Sponsors:   M.D. Anderson Cancer Center;   Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials

L19IL2/L19TNF in Skin Cancer Patients
Conditions:   BCC - Basal Cell Carcinoma;   SCC - Squamous Cell Carcinoma;   Merkel Cell Carcinoma;   Keratoacanthoma of Skin;   Malignant Adnexal Tumors of the Skin (MATS);   Tumors From Cutaneous T-cell Lymphoma (CTCL);   Kaposi Sarcoma Intervention:   Drug: L19IL2/L19TNF Sponsor:   Philogen S.p.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2022 Category: Research Source Type: clinical trials